Physician profile
Patrick K Williams
NPI 1346243136
$643.47
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $51.48 · 2021: $154.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $169.00 | 2019 | |
| W. L. Gore & Associates, INC. | $96.92 | 2019-2020 | |
| Amarin Pharma, INC. | $54.46 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.78 | 2021 | |
| Abbott Laboratories | $44.43 | 2019-2021 | |
| Medtronic Vascular, INC. | $35.54 | 2019-2020 | |
| Teleflex LLC | $26.86 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $26.81 | 2021 | |
| Sanofi-Aventis U.S. LLC | $26.64 | 2019 | |
| Boston Scientific Corporation | $22.74 | 2019 | |
| Esperion Therapeutics, INC. | $15.62 | 2021 | |
| Philips North America LLC | $15.18 | 2019 | |
| Pfizer INC. | $13.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.